A Novel Direct Factor Xa Inhibitory Peptide with Anti-Platelet Aggregation Activity from Agkistrodon acutus Venom Hydrolysates

Item

http://www.wikidata.org/entity/Q35672783

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

A Novel Direct Factor Xa Inhib ...... odon acutus Venom Hydrolysates

@ast

A Novel Direct Factor Xa Inhib ...... odon acutus Venom Hydrolysates

@en

type

Item

label

A Novel Direct Factor Xa Inhib ...... odon acutus Venom Hydrolysates

@ast

A Novel Direct Factor Xa Inhib ...... odon acutus Venom Hydrolysates

@en

prefLabel

A Novel Direct Factor Xa Inhib ...... odon acutus Venom Hydrolysates

@ast

A Novel Direct Factor Xa Inhib ...... odon acutus Venom Hydrolysates

@en

P1476

A Novel Direct Factor Xa Inhib ...... odon acutus Venom Hydrolysates

@en

P2093

Meimei Chen

http://www.w3.org/2001/XMLSchema#string

Wen Su

http://www.w3.org/2001/XMLSchema#string

Xiaohui Ye

http://www.w3.org/2001/XMLSchema#string

Xin Ming

http://www.w3.org/2001/XMLSchema#string

Xingli Su

http://www.w3.org/2001/XMLSchema#string

Yahui Chen

http://www.w3.org/2001/XMLSchema#string

Yi Kong

http://www.w3.org/2001/XMLSchema#string

Ying Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Interactions between aspirin and COX-2 inhibitors or NSAIDs in a rat thrombosis model

Different effects of tirofiban and aspirin plus clopidogrel on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion.

Razaxaban, a direct factor Xa inhibitor, in combination with aspirin and/or clopidogrel improves low-dose antithrombotic activity without enhancing bleeding liability in rabbits

One-year experience with the platelet glycoprotein IIb/IIIa antagonist tirofiban and heparin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II.

Anticoagulant and antithrombotic activity of a new peptide pENW (pGlu-Asn-Trp).

Ac-AP-12, a novel factor Xa anticoagulant peptide from the esophageal glands of adult Ancylostoma caninum.

Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence. Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin.

A new peptide (Ruviprase) purified from the venom of Daboia russelii russelii shows potent anticoagulant activity via non-enzymatic inhibition of thrombin and factor Xa.

A novel, species-specific class of uncompetitive inhibitors of gamma-glutamyl transpeptidase.

Anticoagulant therapy with the oral direct factor Xa inhibitors rivaroxaban, apixaban and edoxaban and the thrombin inhibitor dabigatran etexilate in patients with hepatic impairment.

P2888

srep10846

P304

10846

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP10846

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1050714461

http://www.w3.org/2001/XMLSchema#string

P698

26035670

http://www.w3.org/2001/XMLSchema#string

P921

venom

P932

4451689

http://www.w3.org/2001/XMLSchema#string